Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1959 1
1960 1
1961 2
1963 1
1964 1
1973 1
1978 1
1984 1
1988 1
1998 1
1999 1
2000 2
2002 1
2004 1
2005 1
2006 2
2007 2
2019 3
2020 5
2021 8
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D, Shack L, Woods RR, Turner D, Leonfellner S, Ryan S, Saint-Jacques N, De P, McClure C, Ramanakumar AV, Stuart-Panko H, Engholm G, Walsh PM, Jackson C, Vernon S, Morgan E, Gavin A, Morrison DS, Huws DW, Porter G, Butler J, Bryant H, Currow DC, Hiom S, Parkin DM, Sasieni P, Lambert PC, Møller B, Soerjomataram I, Bray F. Arnold M, et al. Among authors: bardot a. Lancet Oncol. 2019 Nov;20(11):1493-1505. doi: 10.1016/S1470-2045(19)30456-5. Epub 2019 Sep 11. Lancet Oncol. 2019. PMID: 31521509 Free PMC article.
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Morgan E, Soerjomataram I, Gavin AT, Rutherford MJ, Gatenby P, Bardot A, Ferlay J, Bucher O, De P, Engholm G, Jackson C, Kozie S, Little A, Møller B, Shack L, Tervonen H, Thursfield V, Vernon S, Walsh PM, Woods RR, Finley C, Merrett N, O'Connell DL, Reynolds JV, Bray F, Arnold M. Morgan E, et al. Among authors: bardot a. Gut. 2021 Feb;70(2):234-242. doi: 10.1136/gutjnl-2020-321089. Epub 2020 Jun 17. Gut. 2021. PMID: 32554620
Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
Rutherford MJ, Arnold M, Bardot A, Ferlay J, De P, Tervonen H, Little A, Bucher O, St Jacques N, Gavin A, Engholm G, Møller B, O'Connell DL, Merrett N, Parkin DM, Bray F, Soerjomataram I. Rutherford MJ, et al. Among authors: bardot a. Int J Cancer. 2021 Dec 15;149(12):2020-2031. doi: 10.1002/ijc.33767. Epub 2021 Sep 14. Int J Cancer. 2021. PMID: 34460109
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
Cabasag CJ, Butler J, Arnold M, Rutherford M, Bardot A, Ferlay J, Morgan E, Møller B, Gavin A, Norell CH, Harrison S, Saint-Jacques N, Eden M, Rous B, Nordin A, Hanna L, Kwon J, Cohen PA, Altman AD, Shack L, Kozie S, Engholm G, De P, Sykes P, Porter G, Ferguson S, Walsh P, Trevithick R, Tervonen H, O'Connell D, Bray F, Soerjomataram I. Cabasag CJ, et al. Among authors: bardot a. Gynecol Oncol. 2020 Apr;157(1):234-244. doi: 10.1016/j.ygyno.2019.12.047. Epub 2020 Jan 28. Gynecol Oncol. 2020. PMID: 32005583
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Grønlie Guren M, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Aagard Thomsen L, Møller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I. Pilleron S, et al. Among authors: bardot a. Int J Cancer. 2021 Apr 1;148(7):1575-1585. doi: 10.1002/ijc.33326. Epub 2020 Oct 14. Int J Cancer. 2021. PMID: 33006395 Free article.
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, Ferlay J, Tervonen H, Shack L, Woods RR, Saint-Jacques N, De P, McClure C, Engholm G, Gavin AT, Morgan E, Walsh PM, Jackson C, Porter G, Møller B, Bucher O, Eden M, O'Connell DL, Bray F, Soerjomataram I. Araghi M, et al. Among authors: bardot a. Gut. 2021 Jan;70(1):114-126. doi: 10.1136/gutjnl-2020-320625. Epub 2020 Jun 1. Gut. 2021. PMID: 32482683
Changes in colorectal cancer incidence in seven high-income countries: a population-based study.
Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, De P, Tervonen H, Walsh PM, Bucher O, Engholm G, Jackson C, McClure C, Woods RR, Saint-Jacques N, Morgan E, Ransom D, Thursfield V, Møller B, Leonfellner S, Guren MG, Bray F, Arnold M. Araghi M, et al. Among authors: bardot a. Lancet Gastroenterol Hepatol. 2019 Jul;4(7):511-518. doi: 10.1016/S2468-1253(19)30147-5. Epub 2019 May 16. Lancet Gastroenterol Hepatol. 2019. PMID: 31105047
The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
Morgan E, Arnold M, Rutherford MJ, Bardot A, Ferlay J, De P, Engholm G, Jackson C, Little A, Saint-Jacques N, Walsh P, Woods RR, O'Connell DL, Bray F, Parkin DM, Soerjomataram I. Morgan E, et al. Among authors: bardot a. Int J Cancer. 2021 Sep 1;149(5):1013-1020. doi: 10.1002/ijc.33620. Epub 2021 May 20. Int J Cancer. 2021. PMID: 33932300 Free article.
Impact of the COVID-19 pandemic on population-based cancer registry.
Soerjomataram I, Bardot A, Aitken J, Piñeros M, Znaor A, Steliarova-Foucher E, Kohler B, Bettio M, Matsuda T, de Camargo Cancela M, Mery L, Bray F. Soerjomataram I, et al. Among authors: bardot a. Int J Cancer. 2022 Jan 15;150(2):273-278. doi: 10.1002/ijc.33792. Epub 2021 Sep 18. Int J Cancer. 2022. PMID: 34480348 Free PMC article.
Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study.
Myklebust TÅ, Andersson T, Bardot A, Vernon S, Gavin A, Fitzpatrick D, Jerm MB, Rutherford M, Parkin DM, Sasieni P, Arnold M, Soerjomataram I, Bray F, Lambert PC, Møller B. Myklebust TÅ, et al. Among authors: bardot a. Cancer Epidemiol. 2020 Aug;67:101759. doi: 10.1016/j.canep.2020.101759. Epub 2020 Jun 13. Cancer Epidemiol. 2020. PMID: 32544801 Free article.
36 results